Reuters logo
10 months ago
BRIEF-FDA approves Astrazeneca's blood-based companion diagnostic for Tagrisso (osimertinib)
September 29, 2016 / 11:31 AM / 10 months ago

BRIEF-FDA approves Astrazeneca's blood-based companion diagnostic for Tagrisso (osimertinib)

1 Min Read

Sept 29 (Reuters) - Astrazeneca Plc

* U.S. FDA has approved a blood-based companion diagnostic for Tagrisso (osimertinib) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below